4-Methyl-5-phenyl-1,3-oxazolidine
| Identifiers | |
|---|---|
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C10H13NO |
| Molar mass | 163.220 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
4-Methyl-5-phenyl-1,3-oxazolidine is a recreational designer drug with stimulant effects. It is the ring-contracted analogue of phenmetrazine, having a 5 membered oxazolidine ring in place of the 6 membered morpholine core of phenmetrazine, and has similar stimulant effects with only slightly lower potency, though less chemical stability due to the acid-sensitive oxazolidine ring.[1][2]
See also
- Substituted phenylmorpholine
- List of aminorex analogues
- 3-Chlorophenmetrazine
- 3-Fluorophenmetrazine
- 4-Methylaminorex
References
- ^ Kalm MJ (November 1960). "3-Imidomethyloxazolidines". The Journal of Organic Chemistry. 25 (11): 1929–1937. doi:10.1021/jo01081a026.
- ^ Valter K, Arrizabalaga P (1998). Designer Drugs Directory. Elsevier. pp. 129, 135. ISBN 978-0-444-20525-4.
External links
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.